Nephrogenic Systemic Fibrosis News and Research RSS. New high-performance, safe MRI contrast agent for 3D vascular mapping. Heart attack and stroke are the first and second leading causes of death ...

Nephrogenic systemic fibrosis (NSF), a systemic fibrosing disorder, was first recognized in 1997 and described as a new disease in 2000. Initially considered a dermal disorder that occurred ...

Nephrogenic systemic fibrosis can cause a thickening and hardening of the skin, heart and lungs—and cause painful contracting of the joints.

Improved protocols for contrast agents eliminates new cases of nephrogenic systemic fibrosis. ScienceDaily. Retrieved June 2, 2025 from www.sciencedaily.com / releases / 2011 / 05 / 110503081004.htm.

Unlike patients with scleromyxedema, in whom skin thickening can occur on the head, neck, arms and upper trunk, our patient exhibited skin thickening predominantly on the extremities and abdomen ...

Nephrogenic systemic fibrosis (NSF) is a serious, recently recognized complication of renal failure that causes cutaneous and visceral fibrosis. Research has been limited to small case series. To ...

Even at very high doses, gadolinium-based contrast agents alone are not sufficient to cause nephrogenic systemic fibrosis (NSF) in patients with kidney problems, according to a study performed at ...

Cause Of Debilitating Skin Condition Suggested Date: September 25, 2007 Source: Wake Forest University Baptist Medical Center Summary: New findings suggest why some people with kidney failure can ...

Nephrogenic Systemic Fibrosis (NSF) is a rare and serious disease which involves fibrosis of the skin, joints, eyes and internal organs. Though its cause is not fully understood, doctors have ...

Background: A 61-year-old female with end-stage renal disease who was undergoing hemodialysis presented with an 8-week history of upper and lower extremity weakness associated with skin tightness ...

Based on the information we have about NSF—advanced kidney disease as a risk factor, GBCA as a trigger, and several potential cofactors—one can put forth reasonable clinical practice ...

Diagnosis Nephrogenic fibrosing dermopathy/nephrogenic systemic fibrosis. Management Methylprednisolone, thalidomide and physical therapy. You have full access to this article via your institution.